Literature DB >> 17702894

Stromally expressed c-Jun regulates proliferation of prostate epithelial cells.

Wenhua Li1, Chin-Lee Wu, Phillip G Febbo, Aria F Olumi.   

Abstract

Stromal-epithelial interactions play a critical role in development of benign prostatic hyperplasia. We have previously shown that stromal cells associated with prostatic carcinoma can potentiate proliferation and reduce cell death of prostatic epithelial cells. Genetic alterations in stromal cells affect stromal-epithelial interactions and modulate epithelial growth. The c-Jun proteins that are early transcription factor molecules have been shown to regulate stromal-epithelial interactions via paracrine signals. Moreover, the Jun-family member proteins have been shown to play an important role in proper development of the genitourinary organs. In this study, we show that c-Jun protein in fibroblasts regulates production and paracrine signals of insulin-like growth factor-1 (IGF-1). c-jun(+/+) fibroblasts secrete higher levels of IGF-1 and stimulate benign prostatic hyperplasia-1 cellular proliferation. In addition, stromally produced IGF-1 up-regulates epithelial mitogen-activated protein kinase, Akt, and cyclin D protein levels while down-regulating the cyclin-dependent kinase inhibitor p27. These data suggest that stromally expressed c-Jun may promote prostatic epithelial proliferation through IGF-1 as a paracrine signal that, in turn, can promote prostate epithelial proliferation. Identification of the signal transduction pathways between prostate epithelial cells and the surrounding stromal cells will improve our understanding of the normal and abnormal biology in prostatic diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17702894      PMCID: PMC1988869          DOI: 10.2353/ajpath.2007.070285

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  65 in total

1.  Ligand-dependent inhibition of beta-catenin/TCF signaling by androgen receptor.

Authors:  Dennis R Chesire; William B Isaacs
Journal:  Oncogene       Date:  2002-12-05       Impact factor: 9.867

Review 2.  Function of AP-1 target genes in mesenchymal-epithelial cross-talk in skin.

Authors:  Peter Angel; Axel Szabowski
Journal:  Biochem Pharmacol       Date:  2002-09       Impact factor: 5.858

3.  The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.

Authors:  Chunrong Yu; Mohamed Rahmani; Yun Dai; Daniel Conrad; Geoffrey Krystal; Paul Dent; Steven Grant
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

4.  Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling.

Authors:  M Marderosian; A Sharma; A P Funk; R Vartanian; J Masri; O D Jo; J F Gera
Journal:  Oncogene       Date:  2006-05-15       Impact factor: 9.867

5.  Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma.

Authors:  Gustavo E Ayala; Hong Dai; Salahaldin A Tahir; Rile Li; Terry Timme; Michael Ittmann; Anna Frolov; Thomas M Wheeler; David Rowley; Timothy C Thompson
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

6.  Molecular regulation of the IGF-binding protein-4 protease system in human fibroblasts: identification of a novel inducible inhibitor.

Authors:  Bing-Kun Chen; Michael T Overgaard; Laurie K Bale; Zachary T Resch; Michael Christiansen; Claus Oxvig; Cheryl A Conover
Journal:  Endocrinology       Date:  2002-04       Impact factor: 4.736

Review 7.  Role of stroma in carcinogenesis of the prostate.

Authors:  Gerald R Cunha; Simon W Hayward; Y Z Wang
Journal:  Differentiation       Date:  2002-12       Impact factor: 3.880

Review 8.  Role of the stromal microenvironment in carcinogenesis of the prostate.

Authors:  Gerald R Cunha; Simon W Hayward; Y Z Wang; William A Ricke
Journal:  Int J Cancer       Date:  2003-10-20       Impact factor: 7.396

9.  Gene expression correlates of clinical prostate cancer behavior.

Authors:  Dinesh Singh; Phillip G Febbo; Kenneth Ross; Donald G Jackson; Judith Manola; Christine Ladd; Pablo Tamayo; Andrew A Renshaw; Anthony V D'Amico; Jerome P Richie; Eric S Lander; Massimo Loda; Philip W Kantoff; Todd R Golub; William R Sellers
Journal:  Cancer Cell       Date:  2002-03       Impact factor: 31.743

10.  Development of mice expressing a single D-type cyclin.

Authors:  Maria A Ciemerych; Anna M Kenney; Ewa Sicinska; Ilona Kalaszczynska; Roderick T Bronson; David H Rowitch; Humphrey Gardner; Piotr Sicinski
Journal:  Genes Dev       Date:  2002-12-15       Impact factor: 11.361

View more
  23 in total

1.  Age-related histological and zinc content changes in adult nonhyperplastic prostate glands.

Authors:  Vladimir Zaichick; Sofia Zaichick
Journal:  Age (Dordr)       Date:  2013-07-14

Review 2.  [Etiology and pathophysiology of benign prostate hyperplasia].

Authors:  A Roosen; C Gratzke; A Herrlemann; G Magistro; F Strittmatter; P Weinhold; S Tritschler; C G Stief
Journal:  Urologe A       Date:  2013-02       Impact factor: 0.639

3.  Surgical intervention for symptomatic benign prostatic hyperplasia is correlated with expression of the AP-1 transcription factor network.

Authors:  Opal Lin-Tsai; Peter E Clark; Nicole L Miller; Jay H Fowke; Omar Hameed; Simon W Hayward; Douglas W Strand
Journal:  Prostate       Date:  2014-02-05       Impact factor: 4.104

4.  Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5α-reductase 2.

Authors:  Zongwei Wang; Libing Hu; Keyan Salari; Seth K Bechis; Rongbin Ge; Shulin Wu; Cyrus Rassoulian; Jonathan Pham; Chin-Lee Wu; Shahin Tabatabaei; Douglas W Strand; Aria F Olumi
Journal:  J Pathol       Date:  2017-12       Impact factor: 7.996

5.  Effects of metformin on prostatic tissue of rats with metabolic syndrome and benign prostatic hyperplasia.

Authors:  Congyun Xu; Yan Xu; Zhou Shen; Hangcheng Zhou; Jun Xiao; Tao Huang
Journal:  Int Urol Nephrol       Date:  2018-02-19       Impact factor: 2.370

Review 6.  Personalized medicine for the management of benign prostatic hyperplasia.

Authors:  Seth K Bechis; Alexander G Otsetov; Rongbin Ge; Aria F Olumi
Journal:  J Urol       Date:  2014-02-25       Impact factor: 7.450

7.  Metformin: an antiproliferative agent and methylation regulator in treating prostatic disease?

Authors:  Zongwei Wang; Aria F Olumi
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-08

Review 8.  Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies.

Authors:  Murielle Mimeault; Parmender P Mehta; Ralph Hauke; Surinder K Batra
Journal:  Endocr Rev       Date:  2008-02-21       Impact factor: 19.871

Review 9.  Stroma-epithelium crosstalk in prostate cancer.

Authors:  Yi-Nong Niu; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2008-12-22       Impact factor: 3.285

10.  [Development of a three-dimensional primary prostate cancer cell culture model].

Authors:  V Jung; M Saar; R Grobholz; M Stöckle; G Unteregger; J Kamradt
Journal:  Urologe A       Date:  2008-09       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.